Abstract
A privileged structure has been identified within the 1,300-member diversified library by rational selection of the compounds to be tested prior to the screening towards enzymatic β-secretase (BACE-1) assay. The identified hexahydrobenzothiazole privileged structure has been optimised and a preliminary structureactivity study has been performed.
Keywords: Diversified chemical library, screening, privileged structure, β-secretase (BACE-1), Alzheimer's disease, hexahydrobenzothiazole
Letters in Drug Design & Discovery
Title: Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition
Volume: 2 Issue: 8
Author(s): Nicolas Pietrancosta, Gilles Quelever, Cedrik Garino, Younes Laras, Stephane Burlet and Jean-Louis Kraus
Affiliation:
Keywords: Diversified chemical library, screening, privileged structure, β-secretase (BACE-1), Alzheimer's disease, hexahydrobenzothiazole
Abstract: A privileged structure has been identified within the 1,300-member diversified library by rational selection of the compounds to be tested prior to the screening towards enzymatic β-secretase (BACE-1) assay. The identified hexahydrobenzothiazole privileged structure has been optimised and a preliminary structureactivity study has been performed.
Export Options
About this article
Cite this article as:
Pietrancosta Nicolas, Quelever Gilles, Garino Cedrik, Laras Younes, Burlet Stephane and Kraus Jean-Louis, Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition, Letters in Drug Design & Discovery 2005; 2 (8) . https://dx.doi.org/10.2174/157018005774717352
DOI https://dx.doi.org/10.2174/157018005774717352 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Humanin; A Defender Against Alzheimers Disease?
Recent Patents on CNS Drug Discovery (Discontinued) Characterization of the Effect of a Novel γ-secretase Modulator on Aβ: A Clinically Translatable Model
Current Pharmaceutical Design Jun Dimerization Protein 2: A Multifunctional Transcription Factor in Mammalian Cells
Current Genomics The Role of Orexin System in Antipsychotics Induced Weight Gain
Current Psychiatry Reviews Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage Failures
Current Drug Targets Neuromuscular Blockade in the Optimal Management of Mechanical Ventilation of Patients with Respiratory Distress
Current Respiratory Medicine Reviews Brain Perfusion SPECT with Brodmann Areas Analysis in Differentiating Frontotemporal Dementia Subtypes
Current Alzheimer Research Biological Active Peptides from Marine Sources Related to Gut Hormones
Current Protein & Peptide Science Free Radicals Generated by Post-Prandial Oxidative Burst in the Early Alterations of Vascular Contractility
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Is Brain-Derived Neurotrophic Factor: A Common Link Between Neurodegenerative Disorders and Cancer?
Current Alzheimer Research Diagnosis and Management of Lynch Syndrome
Recent Patents on Regenerative Medicine Disaggregating Chaperones: An Unfolding Story
Current Protein & Peptide Science Structural Basis of Agonist Selectivity for Different nAChR Subtypes: Insights from Crystal Structures, Mutation Experiments and Molecular Simulations
Current Pharmaceutical Design Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study
Current Vascular Pharmacology Editorial [Hot Topic: New Avenues of Research on Multiple Sclerosis from the Perspective of Chronic Cerebrospinal Venous Insufficiency Paradigm (Guest Editor: Marian Simka)]
Reviews on Recent Clinical Trials Dietary Patterns in Alzheimers Disease and Cognitive Aging
Current Alzheimer Research Histone Acetylation in Neurodevelopment
Current Pharmaceutical Design Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Current Pharmaceutical Design Pharmacokinetics and Tissue Distribution Study of Ferruginol in Wistar Rat by High-performance Liquid Chromatography
Current Pharmaceutical Analysis